|
Match
|
Document |
Document Title |
|
|
5068104 |
Live vaccine for coccidiosis utilizing coccidial sporozoites
Methods and compositions are disclosed for vaccinating warm-blooded animals against coccidiosis utilizing suspensions of excysted coccidial sporozoites in physiologically balanced medium containing...
|
|
|
5066495 |
Processes for the preparation of pharmaceutical compositions containing bromocriptine having high stability and related products
Processes for the preparation of bromocriptine tablets or capsules wherein the active ingredient is protected by inclusion in an excipient or by separated granulation of the excipients and mixing...
|
|
|
5063057 |
Cosmetic capsules
A cosmetic product is provided that stores a cosmetic composition in a capsule having a round body with hollow chamber forming a major portion of the capsule, a tab forming a minor portion of the...
|
|
|
5057322 |
Method of treating mast cell disease
A method of treating a patient suffering from mast cell disease comprising daily administration to such patient of from about 1 to about 150 mg of a pure narcotic antagonist, e.g., nalmefene or...
|
|
|
5047418 |
Method of stimulating histamine H.sub.3 -receptors
A pharmaceutical composition is described which comprises a pharmaceutically acceptable carrier and a compound of the formula (1): ##STR1## or a pharmaceutically acceptable salt thereof wherein X...
|
|
|
5043167 |
Galenic formulations with programmed release
New galenic formulations with programmed release, to be administered by the oral route, containing as the active ingredient a drug selected from the non steroidal antiinflammatory, bronchodilator,...
|
|
|
5037698 |
Capsule filling employing hygroscopic components
Capsules containing a hygroscopic or deliquescent component are stabilized by a) forming a mixture of the hydrogscopic or deliquescent compound with a sufficient quantity of water to achieve an...
|
|
|
5035896 |
Water insoluble drugs coated by coacervated fish gelatin
According to this invention, the combination of a solid particulate water insoluble drug with a solid fish gelatin coating is produced by coacervation of the fish gelatin. The fish gelatin being...
|
|
|
5028432 |
Pharmaceutical capsules containing panetidine
The invention relates to a pharmaceutical composition in the form of a gelatin capsules consisting of a filling containing as active ingredient ranitidine or a physiologically acceptable salt...
|
|
|
5007790 |
Sustained-release oral drug dosage form
Sustained-release oral drug-dosage forms that release drug in solution at a rate controlled by the solubility of the drug are described. The dosage form comprises a tablet or capsule which...
|
|
|
5006344 |
Fosinopril tablet formulations
Shelf stable tablets containing fosinopril sodium are prepared by employing either sodium stearyl fumarate or hydrogenated vegetable oil as the lubricant. The tablets can contain conventional...
|
|
|
4997657 |
Method for improving skin smoothness
A composition, particularly an oral composition, for improving the smoothness of the skin, wherein GLA or DGLA or both as such or in the form of physiologically acceptable and equivalent...
|
|
|
4987031 |
Capsule
The present invention relates to gelatin composite for the use of capsules to fill medicine and the like, coating agents or binding agents of tablets, casing materials and so on. A gelatin...
|
|
|
4981695 |
Composition comprising L-dopa
The present invention relates to a multiple-unit-dose comprising L-dopa as pharmaceutically active compound, whereby the composition provides a release of L-dopa in accordance with a test in...
|
|
|
4980170 |
Pharmaceutical formulation as well as a process for its preparation
A new pharmaceutical formulation as well as a process for its preparation are described, in which the active ingredient in one pharmaceutical form is present in retarded release form in one part,...
|
|
|
4978533 |
Liquid nifidipine composition
A gelatin capsule form of nifedipine dosage unit containing from 12-20 parts by wt of glycerin per part by wt of nifedipine.
|
|
|
4976965 |
Coronary affecting medicinal composition
Coronary affecting medicinal compositions which in addition to a coronary affecting substance selected from the group consisting of isosorbide nitrates and dihydropyridines contain an alkylene...
|
|
|
4973480 |
Tamper evident pharmaceutical capsule
A tamper evident pharmaceutical capsule which contains an active agent. The capsule is coated on its external surfaces to provide an indication of tampering.
|
|
|
4970076 |
Fatty acid composition
Composition of a cyclosporin and GLA and DGLA or derivative thereof convertible in the body thereto alone or in a pharmaceutical diluent or carrier.
|
|
|
4968506 |
Pharmaceutical dosage with core of N-acetyl cystein
The present invention relates to a novel pharmaceutical composition comprising N-acetyl cysteine, wherein the composition releases N-acetyl cysteine in accordance with the United States Pharmacopea...
|
|
|
4954342 |
Pharmaceutical composition for intrarectal administration of a calcitonin and unit dosage forms prepared therefrom
New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active...
|
|
|
4954347 |
Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
A pharmaceutical composition for the treatment of cardiac arrhythmia comprising an effective amount of propafenone in combination with a subtherapeutic amount of quinidine, such that the quinidine...
|
|
|
4954346 |
Orally administrable nifedipine solution in a solid light resistant dosage form
A solid dosage form having a fill composition encased in a shell composition; the fill composition comprising (a) 5-60 mg of nifedipine; (b) a 5-7 membered cyclic pharmaceutically acceptable...
|
|
|
4952410 |
Pharmaceutical products of moxonidine and hydrochlorothiazide
Pharmaceutical composition containing moxonidine (4-chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrim
idine) or its pharmaceutically acceptable salts and hydrochlorothiazide...
|
|
|
4950689 |
Pectin delivery system
An ingestible gel confectionary delivery system which includes a pectin gel component in an amount sufficient to form a gel confectionary unit, and an edible insoluble solid in an amount sufficient...
|
|
|
4948591 |
Soft capsular preparation of sodium picosulfate
A soft capsular preparation comprising a polyethylene glycol solution of sodium picosulfate. The soft capsular preparation is stable over a prolonged storage time and is convenient to carry around....
|
|
|
4944949 |
Pharmaceutical delivery systems
Non-steroidal anti-inflammatory drugs (NSAIDs) including diclofenac, flufenamic acid, flurbiprofen, ibuprofen, indomethacin, ketoprofen, naproxen, phenylbutazone, piroxicam and sulindac are...
|
|
|
4938966 |
Controlled release flecainide acetate formulation
Controlled release pharmaceutical formulations containing flecainide acetate and methods of suppressing arrhythmia using the formulations are described.
|
|
|
4935243 |
Chewable, edible soft gelatin capsule
In accordance with the present invention, there is provided a chewable, edible soft gelatin capsule which comprises a shell comprising water, gelatin, plasticizer, and an amount of hydrogenated...
|
|
|
4927638 |
Etoposide solutions
A solution of etoposide in dimethylisosorbide is disclosed. The solution is useful for filling gelatin capsules and may also be formulated into parenteral dosage forms.
|
|
|
4925672 |
Products containing a calcium antagonist and a lipid-lowering agent
Combinations of calcium antagonists and lipid-lowering agents are suitable for controlling diseases.
|
|
|
4910021 |
Targeted enternal delivery system
A capsule for oral administration of a pharmaceutically active ingredient contains a pharmaceutical composition comprising the active ingredient, for example, a peptide, an absorption promoter and...
|
|
|
4904476 |
Formulations providing three distinct releases
A therapeutic preparation consisting of three groups of spheroids containing an active medicinal substance. The first group of spheroids is uncoated and rapidly disintegrates upon ingestion to...
|
|
|
4895726 |
Novel dosage form of fenofibrate
The present invention relates to a novel dosage form of fenofibrate containing fenofibrate and a solid surfactant which have been co-micronized. It also relates to the method for the preparation of...
|
|
|
4892766 |
Capsules
Hard gelatin capsules are made from gelatin containing up to 10% of a preferably hydrophilic fibrous material. They do not split after storage when filled with hygroscopic or deliquescent materials.
|
|
|
4891229 |
Soft gelatin capsules and processes for their manufacture
Soft gelatin capsules with a gelatin shell, at least one plasticizer and a capsule filling that contains at least one pharmacologically-active substance and a solvent containing at least 50% by...
|
|
|
4883660 |
Gel bases for pharmaceutical compositions
Gel bases for pharmaceutical compositions comprise from about 0.5 to about 10.0% by weight ethoxylated (2 to 30 moles of ethoxylation) behenyl alcohol and from about 90 to 99.5% of a glycol solvent...
|
|
|
4874611 |
Microencapsulated ant bait
A method of manufacture and the product made thereby are set forth; in the preferred and illustrated embodiment, a core including an insect poison is encapsulated by shell material melting and...
|
|
|
4874613 |
Taste concealing pharmaceutical dosage unit
A pharmaceutical dosage unit suitable for masking the unpleasant taste of orally administered pharmaceutical agents and which facilitates swallowing comprises a plurality of subdosage units...
|
|
|
4869904 |
Sustained release drug preparation
Now is provided a new sustained release drug preparation comprising such an inclusion complex of a medical compound with a hydrophobic cyclodextrin derivative, e.g. ethylated cyclodextrins, which...
|
|
|
4865850 |
Dietary fat reduction
A method and a composition for accumulating and the binding of food fats in an animal body gastrointestinal tract. The method and composition rely upon non-biodegradable collagen particles, such as...
|
|
|
H000672 |
Stable antifungal capsule formulation
In accordance with the present invention an antifungal capsule formulation providing enhanced stability for antifungal agents subject to oxidative degradation, e.g. nystatin, is disclosed. The new...
|
|
|
4861599 |
Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
Several methods are disclosed for the preparation of oral pharmaceutical forms with delayed release of rhein and its derivatives. The pharmaceutically active ingredient is provided in the form of...
|
|
|
4853230 |
Pharmaceutical formulations of acid labile substances for oral use
Pharmaceutical preparation containing an acid labile compound together with an alkaline reacting compound or an alkaline salt of an acid labile compound optionally together with an alkaline...
|
|
|
4851228 |
Multiparticulate controlled porosity osmotic
The instant invention is directed to a multiparticulate osmotic pump, for the controlled release of a pharmaceutically active agent to an environment of use, said pump comprising: (I) a carrier...
|
|
|
4849227 |
Pharmaceutical compositions
A composition adapted to administer a pharmocologically effective amount of a pharmaceutical agent when ingested orally comprising (a) a pharmaceutical agent; (b) a lipid coating materials; and (c)...
|
|
|
4844926 |
Egg lecithin process
The product is an egg oil which is extracted from eggs, primarily, the yolks of chicken eggs and the method associated therewith to produce a high quality capsule of egg oil (lecithin).
|
|
|
4842865 |
Use of glycofurol for the liquidization of pharmaceutical preparations to be filled into soft gelatine capsules
Use of glycofurol for the liquidization of pharmaceutical preparations containing more than 50% phosphatidyl choline with a high content of unsaturated fatty acids, which preparations can contain...
|
|
|
4837255 |
Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
A gel formation for oral administration having improved palatability comprising an effective hypocholesterolaemic amount of a uniform gelled dispersion of (a) between about 8 and about 20...
|
|
|
4837030 |
Novel controlled release formulations of tetracycline compounds
Pharmaceutical compositions comprising spherical granules including thereon or therein a 7- or 9-akylamino-6-deoxy-6-demethyltetracycline or an acid-addition salt thereof blended with at least one...
|